Global Recombinant Human BMP-2 Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Recombinant Human BMP-2 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Human BMP-2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Human BMP-2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Recombinant Human BMP-2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Recombinant Human BMP-2 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Recombinant Human BMP-2 include 赛默飞世尔, Yeasen Biotechnology (Shanghai), Yantai Zhenghai Bio-Tech, Abbkine Scientific, WEIGAO, Shanghai Zhong Qiao Xin Zhou Biotechnology, Shanghai NovoPro, HANGZHOU JIUYUAN GENE ENGINEERIN and Beijing Baiaolaibo Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Human BMP-2, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Recombinant Human BMP-2, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Human BMP-2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human BMP-2 sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Recombinant Human BMP-2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Recombinant Human BMP-2 sales, projected growth trends, production technology, application and end-user industry.


Recombinant Human BMP-2 Segment by Company

赛默飞世尔
Yeasen Biotechnology (Shanghai)
Yantai Zhenghai Bio-Tech
Abbkine Scientific
WEIGAO
Shanghai Zhong Qiao Xin Zhou Biotechnology
Shanghai NovoPro
HANGZHOU JIUYUAN GENE ENGINEERIN
Beijing Baiaolaibo Technology
STEMCELL Technologies
Sigma Aldrich
Proteintech
CUSABIO TECHNOLOGY
Cgbio
Cell Guidance Systems
Biomol GmbH

Recombinant Human BMP-2 Segment by Type

Powder
Sponge
Others

Recombinant Human BMP-2 Segment by Application

Hospital
Research Institute
Others

Recombinant Human BMP-2 Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human BMP-2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human BMP-2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human BMP-2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Human BMP-2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human BMP-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human BMP-2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Recombinant Human BMP-2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Recombinant Human BMP-2 Market Size, 2020 VS 2024 VS 2031
1.3 Global Recombinant Human BMP-2 Market Size Estimates and Forecasts (2020-2031)
1.4 Global Recombinant Human BMP-2 Sales Estimates and Forecasts (2020-2031)
1.5 Global Recombinant Human BMP-2 Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Recombinant Human BMP-2 Market Dynamics
2.1 Recombinant Human BMP-2 Industry Trends
2.2 Recombinant Human BMP-2 Industry Drivers
2.3 Recombinant Human BMP-2 Industry Opportunities and Challenges
2.4 Recombinant Human BMP-2 Industry Restraints
3 Recombinant Human BMP-2 Market by Manufacturers
3.1 Global Recombinant Human BMP-2 Revenue by Manufacturers (2020-2025)
3.2 Global Recombinant Human BMP-2 Sales by Manufacturers (2020-2025)
3.3 Global Recombinant Human BMP-2 Average Sales Price by Manufacturers (2020-2025)
3.4 Global Recombinant Human BMP-2 Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Recombinant Human BMP-2 Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Recombinant Human BMP-2 Manufacturers, Product Type & Application
3.7 Global Recombinant Human BMP-2 Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Recombinant Human BMP-2 Market CR5 and HHI
3.8.2 Global Top 5 and 10 Recombinant Human BMP-2 Players Market Share by Revenue in 2024
3.8.3 2024 Recombinant Human BMP-2 Tier 1, Tier 2, and Tier 3
4 Recombinant Human BMP-2 Market by Type
4.1 Recombinant Human BMP-2 Type Introduction
4.1.1 Powder
4.1.2 Sponge
4.1.3 Others
4.2 Global Recombinant Human BMP-2 Sales by Type
4.2.1 Global Recombinant Human BMP-2 Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Recombinant Human BMP-2 Sales by Type (2020-2031)
4.2.3 Global Recombinant Human BMP-2 Sales Market Share by Type (2020-2031)
4.3 Global Recombinant Human BMP-2 Revenue by Type
4.3.1 Global Recombinant Human BMP-2 Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Recombinant Human BMP-2 Revenue by Type (2020-2031)
4.3.3 Global Recombinant Human BMP-2 Revenue Market Share by Type (2020-2031)
5 Recombinant Human BMP-2 Market by Application
5.1 Recombinant Human BMP-2 Application Introduction
5.1.1 Hospital
5.1.2 Research Institute
5.1.3 Others
5.2 Global Recombinant Human BMP-2 Sales by Application
5.2.1 Global Recombinant Human BMP-2 Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Recombinant Human BMP-2 Sales by Application (2020-2031)
5.2.3 Global Recombinant Human BMP-2 Sales Market Share by Application (2020-2031)
5.3 Global Recombinant Human BMP-2 Revenue by Application
5.3.1 Global Recombinant Human BMP-2 Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Recombinant Human BMP-2 Revenue by Application (2020-2031)
5.3.3 Global Recombinant Human BMP-2 Revenue Market Share by Application (2020-2031)
6 Global Recombinant Human BMP-2 Sales by Region
6.1 Global Recombinant Human BMP-2 Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Recombinant Human BMP-2 Sales by Region (2020-2031)
6.2.1 Global Recombinant Human BMP-2 Sales by Region (2020-2025)
6.2.2 Global Recombinant Human BMP-2 Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Recombinant Human BMP-2 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Recombinant Human BMP-2 Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Recombinant Human BMP-2 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Recombinant Human BMP-2 Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Recombinant Human BMP-2 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Recombinant Human BMP-2 Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Recombinant Human BMP-2 Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Recombinant Human BMP-2 Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Recombinant Human BMP-2 Revenue by Region
7.1 Global Recombinant Human BMP-2 Revenue by Region
7.1.1 Global Recombinant Human BMP-2 Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Recombinant Human BMP-2 Revenue by Region (2020-2025)
7.1.3 Global Recombinant Human BMP-2 Revenue by Region (2026-2031)
7.1.4 Global Recombinant Human BMP-2 Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Recombinant Human BMP-2 Revenue (2020-2031)
7.2.2 North America Recombinant Human BMP-2 Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Recombinant Human BMP-2 Revenue (2020-2031)
7.3.2 Europe Recombinant Human BMP-2 Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Recombinant Human BMP-2 Revenue (2020-2031)
7.4.2 Asia-Pacific Recombinant Human BMP-2 Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Recombinant Human BMP-2 Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Recombinant Human BMP-2 Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 赛默飞世尔
8.1.1 赛默飞世尔 Comapny Information
8.1.2 赛默飞世尔 Business Overview
8.1.3 赛默飞世尔 Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio
8.1.5 赛默飞世尔 Recent Developments
8.2 Yeasen Biotechnology (Shanghai)
8.2.1 Yeasen Biotechnology (Shanghai) Comapny Information
8.2.2 Yeasen Biotechnology (Shanghai) Business Overview
8.2.3 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio
8.2.5 Yeasen Biotechnology (Shanghai) Recent Developments
8.3 Yantai Zhenghai Bio-Tech
8.3.1 Yantai Zhenghai Bio-Tech Comapny Information
8.3.2 Yantai Zhenghai Bio-Tech Business Overview
8.3.3 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio
8.3.5 Yantai Zhenghai Bio-Tech Recent Developments
8.4 Abbkine Scientific
8.4.1 Abbkine Scientific Comapny Information
8.4.2 Abbkine Scientific Business Overview
8.4.3 Abbkine Scientific Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Abbkine Scientific Recombinant Human BMP-2 Product Portfolio
8.4.5 Abbkine Scientific Recent Developments
8.5 WEIGAO
8.5.1 WEIGAO Comapny Information
8.5.2 WEIGAO Business Overview
8.5.3 WEIGAO Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 WEIGAO Recombinant Human BMP-2 Product Portfolio
8.5.5 WEIGAO Recent Developments
8.6 Shanghai Zhong Qiao Xin Zhou Biotechnology
8.6.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Comapny Information
8.6.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
8.6.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio
8.6.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
8.7 Shanghai NovoPro
8.7.1 Shanghai NovoPro Comapny Information
8.7.2 Shanghai NovoPro Business Overview
8.7.3 Shanghai NovoPro Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio
8.7.5 Shanghai NovoPro Recent Developments
8.8 HANGZHOU JIUYUAN GENE ENGINEERIN
8.8.1 HANGZHOU JIUYUAN GENE ENGINEERIN Comapny Information
8.8.2 HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview
8.8.3 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio
8.8.5 HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments
8.9 Beijing Baiaolaibo Technology
8.9.1 Beijing Baiaolaibo Technology Comapny Information
8.9.2 Beijing Baiaolaibo Technology Business Overview
8.9.3 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio
8.9.5 Beijing Baiaolaibo Technology Recent Developments
8.10 STEMCELL Technologies
8.10.1 STEMCELL Technologies Comapny Information
8.10.2 STEMCELL Technologies Business Overview
8.10.3 STEMCELL Technologies Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio
8.10.5 STEMCELL Technologies Recent Developments
8.11 Sigma Aldrich
8.11.1 Sigma Aldrich Comapny Information
8.11.2 Sigma Aldrich Business Overview
8.11.3 Sigma Aldrich Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Sigma Aldrich Recombinant Human BMP-2 Product Portfolio
8.11.5 Sigma Aldrich Recent Developments
8.12 Proteintech
8.12.1 Proteintech Comapny Information
8.12.2 Proteintech Business Overview
8.12.3 Proteintech Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Proteintech Recombinant Human BMP-2 Product Portfolio
8.12.5 Proteintech Recent Developments
8.13 CUSABIO TECHNOLOGY
8.13.1 CUSABIO TECHNOLOGY Comapny Information
8.13.2 CUSABIO TECHNOLOGY Business Overview
8.13.3 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio
8.13.5 CUSABIO TECHNOLOGY Recent Developments
8.14 Cgbio
8.14.1 Cgbio Comapny Information
8.14.2 Cgbio Business Overview
8.14.3 Cgbio Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Cgbio Recombinant Human BMP-2 Product Portfolio
8.14.5 Cgbio Recent Developments
8.15 Cell Guidance Systems
8.15.1 Cell Guidance Systems Comapny Information
8.15.2 Cell Guidance Systems Business Overview
8.15.3 Cell Guidance Systems Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio
8.15.5 Cell Guidance Systems Recent Developments
8.16 Biomol GmbH
8.16.1 Biomol GmbH Comapny Information
8.16.2 Biomol GmbH Business Overview
8.16.3 Biomol GmbH Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Biomol GmbH Recombinant Human BMP-2 Product Portfolio
8.16.5 Biomol GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Recombinant Human BMP-2 Value Chain Analysis
9.1.1 Recombinant Human BMP-2 Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Recombinant Human BMP-2 Production Mode & Process
9.2 Recombinant Human BMP-2 Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Recombinant Human BMP-2 Distributors
9.2.3 Recombinant Human BMP-2 Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings